Table 3

Time-varying variables

VariableAS exposurep Value
No (n=360)Yes (n=765)
Time to clinical stability (days)3.54 (SD 3.34)4.75 (SD 3.80)p<0.001
Time to oral intake (days)2.14 (SD 2.06)2.39 (SD 1.90)p=0.054
Phase 1 (n=517)Phase 2 (n=248)
Time to AS intervention (days)2.87 (SD 1.11)2.59 (SD 1.67)p=0.016
  • AS,¬†antimicrobial stewardship.